Patent number: 7112426
Abstract: The invention provides human human kinases (PKIN) and polynucleotides which identify and encode PKIN. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PKIN.
Type:
Grant
Filed:
November 1, 2002
Date of Patent:
September 26, 2006
Assignee:
Incyte Corporation
Inventors:
Olga Bandman, Danniel B Nguyen, Narinder K Chawla, April J A Hafalia, Monique G Yao, Ameena R Gandhi, Rajagopal Gururajan, Li Ding, Chandra S Arvizu, Henry Yue, Mariah R Baughn, Catherine M Tribouley, Michael B Thornton, Vicki S Elliott, Yan Lu, Craig H Ison, Janice K Au-Young, Y Tom Tang, Yalda Azimzai, John D Burrill, Gregory A Marcus, Kurt A Zingler, Dyung Aina M Lu, Preeti G Lai, Jayalaxmi Ramkumar, Bridget A Warren, Liam Kearney, Jennifer L Policky, Kavitha Thangavelu, Neil Burford
Publication number: 20060194275
Abstract: The invention provides human transporters and ion channels (TRICH) and polynucleotides which identify and encode TRICH. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of TRICH.
Type:
Application
Filed:
April 12, 2002
Publication date:
August 31, 2006
Applicant:
INCYTE CORPORATION
Inventors:
Mariah Baughn, Vicki Elliott, April Hafalia, Junming Yang, Narinder Chawla, Jayalaxmi Ramkumar, Ian Forsythe, Yan Lu, Y Tom Tang, Henry Yue, Brigitte Raumann, Preeti Lal, Yalda Azimzai, Dyung Lu, Ameena Gandhi, Michael Thornton, Danniel Nguyen, Chandra Arvizu, Brooke Emerling, Anita Swarnakar, Monique Yao, Li Ding, Ann He, Jennifer Griffin, Madhusudan Sanjanwala, Kimberly Gietzen, Ernestine Lee, Yuming Xu, Janice Au-Young, Debopriya Das, Soo Lee, Hsin-Ru Chang
Publication number: 20060127894
Abstract: Various embodiments of the invention provide human proteins associated with cell growth, differentiation, and death (CGDD) and polynucleotides which identify and encode CGDD. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of CGDD.
Type:
Application
Filed:
August 8, 2002
Publication date:
June 15, 2006
Applicant:
Incyte Corporation
Inventors:
Yalda Azimzai, Ines Barroso, Mariah Baughn, Shanya Becha, Mark Borowsky, Brendan Duggan, Vicki Elliott, Brooke Emerling, Ian Forsythe, Kimberly Gietzen, Ann Gorvad, Richard Graul, Jennifer Griffin, Rajagopal Gururajan, April Hafalia, Craig Ison, Amy Kable, Farrah Khan, Sally Lee, Soo Lee, Joana Li, Roopa Reddy, Thomas Richardson, William Sprague, Anita Swarnakar, Y. Tom Tang, Bridget Warren, Yuming Xu, Monique Yao, Henry Yue, Huibin Yue
Publication number: 20050186568
Abstract: Various embodiments of the invention provide human kinases and phosphatases (KPP) and polynucleotides which identify and encode KPP. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of KPP.
Type:
Application
Filed:
October 17, 2002
Publication date:
August 25, 2005
Inventors:
Olga Bandman, Mariah Baughn, Shanya Becha, Mark Borowsky, Brendan Duggan, Brooke Emerling, Ian Forsythe, Ameena Ganhi, Jennifer Griffin, Rajagopal Gururajan, April Hafalia, Farrah Khan, Preeti Lal, Ernestine Lee, Soo Lee, Erika Lindquist, Dyung Aina Lu, Yan Lu, Joseph Marquis, Danniel Nguyen, Chandra Arvizu, Jayalaxmi Ramkumar, Shirley Recipon, Thomas Richardson, Anita Swarnakar, Y.Tom Tang, Michael Thornton, Uyen Tran, Narinder Chawla, Bridget Warren, Junming Yang, Monique Yao, Henry Yue, Yeganeh Zebarjadian
Patent number: 6927056
Abstract: The invention provides a human cysteine proteases and polynucleotides which encode those proteases. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists, as well as methods for diagnosing, treating, or preventing disorders associated with aberrant expression of cysteine proteases.
Type:
Grant
Filed:
September 6, 2001
Date of Patent:
August 9, 2005
Assignee:
Incyte Corporation
Inventors:
Stephen Todd, Angelo M. Delegeane, Ameena R. Gandhi, Danniel B. Nguyen, April J. A. Hafalia, Liam Kearney, Yan Lu, Ernestine A. Lee, Narinder K. Chawla, Debopriya Das, Chandra S. Arvizu, Monique G. Yao, Deborah A. Kallick, Vicki S. Elliott, Li Ding, Henry Yue, Roopa M. Reddy, Dyung Aina M. Lu, Jayalaxmi Ramkumar, Junming Yang, Catherine M. Tribouley, Neil Burford, Mariah R. Baughn, Preeti G. Lal, Mark L. Borowsky, Farrah A. Khan, Rajagopal Gururajan, Y. Tom Tang, Janice K. Au-Young, Bridget A. Warren, Roberto Hernandez, Brendan M. Duggan
Publication number: 20050107293
Abstract: Various embodiments of the invention provide human protein modification and maintenance molecules (PMMM) and polynucleotides which identify and encode PMMM. Embodiments of the invention also provide expression vectors, host cells, antibodies, agonists, and antagonists. Other embodiments provide methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PMMM.a.
Type:
Application
Filed:
September 13, 2002
Publication date:
May 19, 2005
Inventors:
William Sprague, Narinder Chawla, Bridget Warren, Y. Tom Tang, Vicki Elliott, Joseph Marquis, Joana Li, Jennifer Griffin, Kimberly Gietzen, Junming Yang, Dyung Lu, Brooke Emerling, Brendan Duggan, Thomas Richardson, Soo Lee, Jayalaxmi Ramkumar, Shanya Becha, Patricia Mason, Anita Swarnakar, Uyen Tran, Amy Kable, April Hafalia, Reena Khare